Michael Bonney, Cubist Pharmaceuticals CEO, discusses the FDA's approval of Sivextro, a new antibiotic designed to treat skin infections. Bonney also explains why so many pharma companies have left the antibiotic space.
An inside look at how management manipulated patient wait times at the Department of Veterans Affairs, with CNBC's Dina Gusovsky.
Researchers have discovered that an FDA-approved arthritis drug may hold the secret to curing hairlessness.
Medical malpractice insurance costs are soaring. Philip Howard, author of "The Rule of Nobody," provides insight to the consequences of increasing malpractice lawsuits, and how to reduce them.
Shire has hired investment bank Citi as an adviser following a wave of deals in the healthcare sector.
New York Times Executive Editor Dean Baquet disclosed that he had a malignant tumor on his kidney that was removed over the weekend.
CNBC's Meg Tirrell takes a look at the companies behind the fight against diabetes.
CNBC's Meg Tirrell reports which pharmaceutical stocks are ready for the future of medicine, including Covidien's swallowable pill-size camera.
David Neeleman, JetBlue founder & AZUL Airlines founder & CEO, and Dr. Florence Comite, Precision Health Care, explain "genetically driven health care," a personalized approach that uses your genetic code to determine the best medications for you.
Why does the U.S. spend so much money on health care? Daniel Kraft, Exponential Medicine executive director, says the U.S. spends a lot of money on "sick" care, not health care, and provides insight to new technology developments in the industry.
Medicare Advantage plans are facing audits that could order them to repay tens of millions of dollars for billing errors.
The Center for Public Integrity found missed chances to corral tens of billions of dollars in Medicare Advantage billing errors.
The Senate has reached a bipartisan deal that would give some veterans a chance to seek out their own care in the private market. Dan Caldwell, Concerned Veterans for America, explains what type of culture at the VA led to this deal.
ZocDoc is a medical care scheduling service allowing users to find and book a doctor online. Cyrus Massoumi, ZocDoc CEO, weighs in on Apple's HealthKit and explains how the free search facility functions.
In 2012, hospitals charged more for every one of 98 common ailments that could be compared to the previous year.
CNBC's Meg Tirrell and Dr. Michael Giordano, senior vice president of oncology and immunosciences development at Bristol-Myers Squibb, discusses advances to cure melanoma and cancer research costs.
Patients can try new once-a-day tablets that dissolve quickly under the tongue and raise tolerance to grass or ragweed pollen, much like the shots.
President Obama announced the resignation of Veterans Affairs Secretary Eric Shinseki. Eric Schnipper, NRAD Medical Associates partner, addresses the major problems with the VA system.
This year's biggest cancer conference begins tomorrow. CNBC's Meg Tirrell reports why immunotherapy drugs will be a key theme with drug makers at ASCO.
The big topic at this year's cancer care conference ASCO will be immunotherapy drugs. CNBC's Meg Tirrell explains how these drugs work.